Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor textual updates: PubMed publications are automatically filled from PubMed, and the revision history now notes v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe government funding status notice about NIH operations has been removed from the page. This change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; the page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedUpdate announces version v3.2.0 and adds a government funding and operating status notice, replacing the previous v3.1.0.SummaryDifference2%

- Check69 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no substantive changes to core content.SummaryDifference0.1%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.